MLYS
Price
$14.52
Change
+$0.39 (+2.76%)
Updated
Aug 15 closing price
Capitalization
962.61M
87 days until earnings call
TRVI
Price
$7.52
Change
+$0.03 (+0.40%)
Updated
Aug 15 closing price
Capitalization
915.76M
81 days until earnings call
Interact to see
Advertisement

MLYS vs TRVI

Header iconMLYS vs TRVI Comparison
Open Charts MLYS vs TRVIBanner chart's image
Mineralys Therapeutics
Price$14.52
Change+$0.39 (+2.76%)
Volume$938.03K
Capitalization962.61M
Trevi Therapeutics
Price$7.52
Change+$0.03 (+0.40%)
Volume$895.36K
Capitalization915.76M
MLYS vs TRVI Comparison Chart in %
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. TRVI commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Hold and TRVI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (MLYS: $14.52 vs. TRVI: $7.52)
Brand notoriety: MLYS and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 113% vs. TRVI: 54%
Market capitalization -- MLYS: $962.61M vs. TRVI: $915.76M
MLYS [@Biotechnology] is valued at $962.61M. TRVI’s [@Biotechnology] market capitalization is $915.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, both MLYS and TRVI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 4 TA indicator(s) are bullish while TRVI’s TA Score has 5 bullish TA indicator(s).

  • MLYS’s TA Score: 4 bullish, 4 bearish.
  • TRVI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both MLYS and TRVI are a good buy in the short-term.

Price Growth

MLYS (@Biotechnology) experienced а +11.69% price change this week, while TRVI (@Biotechnology) price change was +1.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

MLYS is expected to report earnings on Nov 11, 2025.

TRVI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS($963M) has a higher market cap than TRVI($916M). TRVI YTD gains are higher at: 82.524 vs. MLYS (17.953). TRVI has higher annual earnings (EBITDA): -47.23M vs. MLYS (-201.44M). MLYS has more cash in the bank: 343M vs. TRVI (103M). MLYS (0) and TRVI (0) have equivalent revenues.
MLYSTRVIMLYS / TRVI
Capitalization963M916M105%
EBITDA-201.44M-47.23M427%
Gain YTD17.95382.52422%
P/E RatioN/AN/A-
Revenue00-
Total Cash343M103M333%
Total DebtN/A957K-
FUNDAMENTALS RATINGS
TRVI: Fundamental Ratings
TRVI
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLYSTRVI
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DQIAX34.10N/A
N/A
BNY Mellon Equity Income Fund A
FAAIX30.44N/A
N/A
Fidelity Advisor Asset Manager 70% I
AVPEX14.01N/A
N/A
ALPS Global Opportunity Portfolio Cl III
TSCGX18.13-0.04
-0.22%
Thrivent Small Cap Growth S
RLESX25.47-0.17
-0.66%
Russell Inv US Small Cap Equity S

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with BIESF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
+0.40%
BIESF - TRVI
43%
Loosely correlated
N/A
PTGX - TRVI
41%
Loosely correlated
+1.96%
GOSS - TRVI
32%
Poorly correlated
N/A
MLYS - TRVI
31%
Poorly correlated
+2.76%
QURE - TRVI
30%
Poorly correlated
+2.53%
More